Table 1.
Probiotics' effect on immune responses and vaccine efficacy.
| Probiotic strain | Participants | Vaccine | Effects of probiotics on vaccine response | Reference |
|---|---|---|---|---|
|
B. longum BB536 |
Human infants | DTP (diphtheria, pertussis, and tetanus) | An increase in the ratio of IFN-γ/IL-4 secretion cells in the BB536 supplementation group | (92) |
| L. paracasei 431 | Human adults | Inactivated trivalent influenza vaccine | No difference in A/H1N1, A/H3N2, and B strain-specific IgG/No difference in A/H1N1, A/H3N2, and B strain-specific IgA levels in saliva / No difference in seroconversion rates 3 w after vaccination | (118) |
| L. rhamnosus GG | Human pregnant women | Combined diphtheria-tetanus-acellular pertussis-Haemophilus influenza type b vaccine | Lower pneumococcal-specific IgG levels/Lower seroconversion rates for pneumococcal serotypes /Lower tetanus toxoid-specific IgG levels/No difference in Hib-specific IgG levels/Higher tolerogenic T regulatory (Treg) responses | (117) |
|
L. paracasaei MoLac-1 (heat-killed) |
Human adults | Inactivated trivalent influenza vaccine | No differences in natural killer cell activity, neutrophil bactericidal or phagocytosis activity/No difference in IgA, IgG, and IgM levels/Higher H3N2 specific IgG levels/No difference in seroconversion rates | (119) |
| B. lactis BB-12 / L. paracasei 431 | Human adults | Inactivated trivalent influenza vaccine | An increase in influenza-specific IgG levels/Higher seroconversion rates for IgG/Higher influenza-specific IgA levels in saliva /No differences in NK-cells activity, number of CD4+T-lymphocytes and phagocytosis/No differences in INF-γ, IL-2, and IL-10 levels | (95) |
| LGG and inulin | Human adults | Nasal attenuated trivalent influenza vaccine | Increased seroprotection rate to the H3N2 strain, but not to the H1N1 or B strain | (106) |
|
B. longum BL999 /L.rhamnosus LPR |
Human infants | Hepatitis B Virus (HBV), DTP | An improvement in HepB surface antibody responses in subjects receiving monovalent and a DTPa-HepB combination vaccine at 6 months but not those who received 3 monovalent doses | (93) |
| B. bifum / B.infantis/ B.longum/ L.acidophilus | Human infants | Measles-Mumps-Rubella-Varicella vaccine | Higher overall seroconversion rates/No difference in specific seroconversion rates for rubella, mumps, measles, varicella/No difference in the rate of treatment-related adverse effects between the two groups | (96) |
|
L. acidophilus CRL431/ L. rhamnosus GG |
Human adults | Oral polio vaccine | An increase in poliovirus neutralizing antibody levels/ Increase in poliovirus-specific IgA and IgM levels /No change in poliovirus-specific IgG levels | (108) |
| L. casei GG | Human infants | Oral rotavirus vaccine | Higher number of rotavirus-specific IgM secreting cells/ Higher IgA seroconversion rates /Higher IgM seroconversion rates | (107) |
| Escherichia coli Nissle 1917 | Ciprofloxacin (Cipro)-treated Gn piglets colonized with a defined commensal microbiota (DM) | Virulent human rotavirus (HRV) | An increase in the numbers of total immunoglobulin-secreting cells, HRV-specific antibody-secreting cells, activated antibody-forming cells, memory antibody-forming B cells, and naive antibody-forming B cells/ A Decreased in levels of pro-inflammatory but increased levels of immuno-regulatory cytokines and increased frequencies of Toll-like receptor-expressing cells | (109) |
| L.rhamnosus GG | Human gut microbiome transplanted neonatal Gn pig | Attenuated HRV vaccine | Significantly enhancement in HRV-specific IFN-γ producing T cell responses to the AttHRV vaccine. Neither doses of LGG significantly improved the protection rate, HRV-specific IgA and IgG antibody titers in serum, or IgA antibody titers in intestinal contents | (72) |
| L. plantarum | 24-Month-old children | - | An increase in fecal sIgA titer /A Significant positive correlation between TGF-β1,TNF-α, and fecal sIgA | (100) |
| B. longum + gluco-oligosaccharide | Human adults | Influenza seasonal vaccine | Significantly higher number of senescent (CD28–CD57+) helper T cells/Significantly higher plasma levels of anti-CMV IgG and a greater tendency for CMV seropositivity/Higher numbers of CD28–CD57+ helper T cells | (94) |
| L. plantarum GUANKE (LPG) | Mice | SARS-CoV-2 vaccine | Enhancement of SARS-CoV-2 neutralization antibodies production/A boost in specific neutralization antibodies >8-fold in bronchoalveolar lavage and >2-fold in sera when LPG was given immediately after SARS-CoV-2 vaccine inoculation /Persistence in T-cell responses | (103) |
| Lactococcus lactis strain plasma (LC-Plasma) | Human adults | Dengue fever (DF) | Significant reduction in the cumulative incidence days of DF-like symptoms/Significantly reduced severity score in the LC-Plasma group | (111) |
|
Lactobacillus
plantarum Probio-88 |
In vitro and in silico study | SARS-CoV-2 infection | A significant inhibition in the replication of SARS-CoV-2 and the production of reactive oxygen species (ROS) levels/A significant reduction in inflammatory markers such as IFN-α, IFN-β, and IL-6 | (104) |
| probiotic Lactobacillus | Chickens | Herpesvirus of turkeys vaccine | An increase in the expression of major histocompatibility complex (MHC) II on macrophages and B cells in spleen/A decrease in the number of CD4+CD25+ T regulatory | (99) |
| cells in the spleen/ higher expression of IFN-α at 21dpi in the spleen/A decrease in the expression of tumor growth factor (TGF)-β4 | ||||
| probiotic Escherichia coli Nissle (EcN) 1917 | Malnourished piglet model transplanted with human infant fecal microbiota (HIFM) | HRV vaccine | Increased frequencies of activated plasmacytoid dendritic cells (pDC) and activated conventional dendritic cells (cDC)/increased frequencies of systemic activated and memory antibody-forming B cells and IgA+ B cells in the systemic tissues/Increase in the mean numbers of systemic and intestinal HRV-specific IgA antibody-secreting cells (ASCs), as well as HRV-specific IgA antibody titers in serum and small intestinal contents | (110) |
| Bacillus velezensis | Pigeons | Pigeon circovirus (PiCV) | Significant reduction in the PiCV viral load in the feces and spleen of pigeons/Up-regulation in Interferon-gamma (IFN-γ), myxovirus resistance 1 (Mx1), signal transducers and activators of transcription 1 (STAT1), toll-like receptor 2 (TLR2) and 4 (TLR4)gene expression | (115) |
| Lactococcus lactis NZ1330 | BALB/c Mouse Model | Allergy to Amaranthus retroflexus pollens | Significantly reduction in the serum IgE level/Best performance in terms of improving allergies to Th1 and Treg responses | (112) |
| L.acidophilus; L.plantarum; Pediococcus pentosaceus; Saccharomyces cerevisiae; B.subtilis; B.licheniformis | Broiler chickens | Salmonella Enteritidis (SE) vaccine | Diminished the negative effect of live vaccine growth performance/reduced mortality rate, fecal shedding, and re-isolation of SE from liver, spleen, heart, and cecum | (102) |
| long-chain inulin (lcITF) and L.acidophilus W37 (LaW37) | Piglets | Salmonella Typhimurium strains (STM) | Enhanced vaccination efficacy by 2-fold /Higher relative abundance of Prevotellaceae and lower relative abundance of Lactobacillaceae in feces/Increased the relative abundance of fecal lactobacilli was correlated with higher fecal consistency | (105) |
| fecal microbiome+ Clostridium butyricum and Saccharomyces boulardii | Gpiglets | - | Increased the plasma concentrations of IL-23, IL-17, and IL-22, as well as the plasma levels of anti-M.hyo and anti-PCV2 antibodies/ Decreases in inflammation levels and oxidative stress injury, and improvement of intestinal barrier function | (116) |
| L.rhamnosus GG (LGG) | Patients with type 1 diabetes | Betapropiolactone- whole inactivated virus | Reduction in the inflammatory responses (i.e., IFN-γ, IL17A, IL-17F, IL-6, and TNF-α)/Significantly | (120) |
| production of IL-17F prior to and after (90 ± 7 days later) vaccination | ||||
| B. toyonensis BCT-7112T | Ewes of the Corriedale sheep | Recombinant Clostridium perfringens epsilon toxin (rETX) | Higher neutralizing antibody titers/An increase in serum levels for total IgG anti-rETX/Increase IgG isotypes IgG1 and IgG2 /Higher cytokine mRNA transcription levels for IL-2, IFN-γ, and transcription factor Bcl6 | (113) |
| B. toyonensis and Saccharomyces boulardii | Sheep | Clostridium chauvoei vaccine | Significantly higher specific IgG, IgG1, and IgG2 titers/Approximately 24- and 14-fold increases in total IgG levels/ Increased mRNA transcription levels of the IFN-γ, IL2, and Bcl6 genes | (114) |